We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
-13.39%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$100M
AUM Growth
-$190M
Cap. Flow
-$172M
Cap. Flow %
-171.38%
Top 10 Hldgs %
54.37%
Holding
137
New
6
Increased
24
Reduced
74
Closed
27

Sector Composition

1 Healthcare 44.52%
2 Financials 12.7%
3 Technology 11.55%
4 Communication Services 10.08%
5 Consumer Staples 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
1
CVS Health
CVS
$137B
$10.3M 10.27%
110,963
-121
-0.1% -$11.8K
COR icon
2
Cencora
COR
$59.9B
$9.2M 9.19%
65,024
+24
+0% +$3.67K
BMRN icon
3
BioMarin Pharmaceuticals
BMRN
$11.5B
$6.84M 6.83%
82,500
+2,500
+3% +$199K
ZBH icon
4
Zimmer Biomet
ZBH
$17.6B
$6.31M 6.3%
60,030
+12,030
+25% +$1.43M
GBT
5
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.11M 5.11%
160,000
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.22T
$5.03M 5.03%
46,000
APO icon
7
Apollo Global Management
APO
$69.5B
$3.54M 3.53%
72,961
MSFT icon
8
Microsoft
MSFT
$2.93T
$2.87M 2.87%
11,176
-489
-4% -$133K
AAPL icon
9
Apple
AAPL
$4.9T
$2.68M 2.67%
19,571
-584
-3% -$88.4K
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.23T
$2.56M 2.56%
23,480
-2,320
-9% -$273K
BRK.B icon
11
Berkshire Hathaway Class B
BRK.B
$1.06T
$2.17M 2.17%
7,962
-1,534
-16% -$481K
AMZN icon
12
Amazon
AMZN
$2.66T
$2.17M 2.16%
20,380
-620
-3% -$77.6K
PG icon
13
Procter & Gamble
PG
$349B
$1.6M 1.6%
11,119
+55
+0.5% +$8.27K
TSLA icon
14
Tesla
TSLA
$1.43T
$1.29M 1.29%
5,727
-630
-10% -$172K
KO icon
15
Coca-Cola
KO
$351B
$1.15M 1.15%
18,299
+401
+2% +$25.4K
PEP icon
16
PepsiCo
PEP
$187B
$1.07M 1.07%
6,415
+117
+2% +$19.7K
VYNE icon
17
VYNE Therapeutics
VYNE
$25.4M
$1.04M 1.04%
148,333
JPM icon
18
JPMorgan Chase
JPM
$907B
$995K 0.99%
8,833
+440
+5% +$54.5K
UNH icon
19
UnitedHealth
UNH
$387B
$908K 0.91%
1,767
+12
+0.7% +$6.03K
META icon
20
Meta Platforms (Facebook)
META
$1.64T
$859K 0.86%
5,327
-1,183
-18% -$228K
LIN icon
21
Linde
LIN
$237B
$839K 0.84%
2,918
-144
-5% -$45K
V icon
22
Visa
V
$682B
$826K 0.83%
4,195
-960
-19% -$198K
JNJ icon
23
Johnson & Johnson
JNJ
$609B
$811K 0.81%
4,566
-177
-4% -$31.5K
MA icon
24
Mastercard
MA
$480B
$711K 0.71%
2,253
-515
-19% -$177K
NVDA icon
25
NVIDIA
NVDA
$4.91T
$707K 0.71%
46,610
-7,810
-14% -$147K

Similar funds

DSC Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, DSC Advisors held 137 positions worth $100M, down 66% from $290M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

DSC Advisors withdrew a net $172M in Q2 2022, closing 27 positions and reducing 74 holdings. Its most notable exit was HyreCar Inc. Common Stock, an estimated $501K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

Against the trend, DSC Advisors opened a new position in VanEck Digital Transformation ETF worth $262K.

  • DSC Advisors's largest Q2 2022 buy was VanEck Digital Transformation ETF: 60,000 shares worth $262K.
  • DSC Advisors added most to Zimmer Biomet in Q2 2022, an estimated $1.43M increase.
  • DSC Advisors's biggest Q2 2022 reduction was Eargo, Inc. Common Stock, cutting an estimated $512K.
  • DSC Advisors fully exited HyreCar Inc. Common Stock in Q2 2022, selling an estimated $501K.
  • DSC Advisors's ten largest holdings make up 54% of its $100M portfolio in Q2 2022.
  • DSC Advisors opened 6 new positions and closed 27 in Q2 2022.
  • DSC Advisors's portfolio value fell 66% quarter-over-quarter to $100M.

Based on DSC Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.